Entrada Therapeutics (TRDA) Institutional Ownership → Free report reveals “two-baggers” for 2024 (From TradingTips) (Ad) Free TRDA Stock Alerts $14.99 +0.04 (+0.27%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Entrada Therapeutics (NASDAQ:TRDA)CurrentInstitutional OwnershipPercentage86.39%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$2.85MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$9.80M Get TRDA Insider Trade Alerts Want to know when executives and insiders are buying or selling Entrada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRDA Institutional Buying and Selling by Quarter Ad DTIBad week to own stocks - see thisThe S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.Click here and I’ll give you all the details. Entrada Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 California State Teachers Retirement System12,631$179K0.0%-11.1%0.037% 5/15/2024 Price T Rowe Associates Inc. MD2,753,357$39.02M0.0%-8.5%8.156% 5/10/2024 Acadian Asset Management LLC5,685$79K0.0%N/A0.017% 5/10/2024 Vanguard Group Inc.1,078,908$15.29M0.0%+1.3%3.203% 5/7/2024 SG Americas Securities LLC7,687$109K0.0%-34.4%0.023% 4/30/2024 Allspring Global Investments Holdings LLC14,763$209K0.0%+427.6%0.044% Get the Latest News and Ratings for TRDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/25/2024 New York State Teachers Retirement System1,915$27K0.0%N/A0.006% 4/18/2024 Allspring Global Investments Holdings LLC14,763$209K0.0%+427.6%0.044% 3/5/2024 Wellington Management Group LLP1,047,780$15.81M0.0%+0.2%3.140% 2/14/2024 72 Investment Holdings LLC172,600$2.61M11.6%-66.1%0.517% 2/13/2024 Tower Research Capital LLC TRC5,780$87K0.0%+476.3%0.017% 2/6/2024 Swiss National Bank23,000$347K0.0%-8.7%0.069% 1/30/2024 Strs Ohio24,100$363K0.0%+792.6%0.072% 1/12/2024 SG Americas Securities LLC11,714$177K0.0%+27.7%0.035% 12/1/2023 Wellington Management Group LLP1,045,652$16.52M0.0%+2.6%3.134% 11/15/2023 Redmile Group LLC1,284,000$20.29M1.0%-2.1%3.848% 11/14/2023 Corton Capital Inc.10,485$166K0.1%-42.0%0.031% 10/27/2023 Allspring Global Investments Holdings LLC2,798$44K0.0%N/A0.008% 10/27/2023 TD Asset Management Inc119,254$1.88M0.0%+100.0%0.359% 10/13/2023 SG Americas Securities LLC9,174$145K0.0%N/A0.028% 9/21/2023 Barclays PLC6,440$97K0.0%-37.0%0.019% 8/11/2023 Nan Fung Group Holdings Ltd49,082$743K0.5%-33.3%0.148% 8/4/2023 American International Group Inc.10,299$156K0.0%N/A0.031% 7/31/2023 Strs Ohio2,700$40K0.0%N/A0.008% 5/11/2023CHI Advisors LLC56,374$817K0.2%N/A0.170% 5/9/2023 Y Intercept Hong Kong Ltd10,188$148K0.0%N/A0.031% 2/14/2023 683 Capital Management LLC10,355$140K0.0%N/A0.033% 2/9/2023 Citigroup Inc.51,042$690K0.0%+3,124.4%0.163% 2/8/2023 Swiss National Bank26,500$358K0.0%N/A0.084% 11/15/2022 TCG Crossover Management LLC642,189$10.12M3.0%-3.2%2.045% 11/15/2022 Laurion Capital Management LP199,066$3.14M0.0%+54.2%0.634% 11/10/2022 Nan Fung Group Holdings Ltd141,593$2.23M1.4%-18.4%0.451% 11/7/2022 TD Asset Management Inc.59,496$925K0.0%+3.2%0.189% 8/15/2022 Laurion Capital Management LP129,066$1.57M0.0%N/A0.411% 5/27/2022 Walleye Capital LLC44,652$419K0.0%N/A0.142% 5/5/2022 New York State Common Retirement Fund4,880$46K0.0%N/A0.016% 2/18/2022 TCG Crossover Management LLC663,694$11.36M5.3%N/A2.126% 2/14/2022 Redmile Group LLC1,954,420$33.46M0.8%N/A6.262% 2/14/2022 72 Investment Holdings LLC509,024$8.71M7.7%N/A1.631% 2/14/2022 Suvretta Capital Management LLC106,000$1.82M0.0%N/A0.340% Automatic Income (from home) (Ad)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video2/14/2022 Ghisallo Capital Management LLC15,000$257K0.0%N/A0.048% 2/14/2022 Goldman Sachs Group Inc.7,626,182$130.56M0.0%N/A24.433% 2/11/2022 MPM Asset Management LLC4,425,784$75.77M16.4%N/A14.179% 2/10/2022 TD Asset Management Inc.57,675$987K0.0%N/A0.185% 2/8/2022 Northern Trust Corp79,483$1.36M0.0%N/A0.255% 2/3/2022 5AM Venture Management LLC4,408,379$75.47M14.2%N/A14.124% (Data available from 1/1/2016 forward) TRDA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRDA shares? During the previous two years, 26 institutional investors and hedge funds held shares of Entrada Therapeutics. The most heavily invested institutionals were Price T Rowe Associates Inc. MD ($39.02M), Redmile Group LLC ($20.29M), Wellington Management Group LLP ($15.81M), Vanguard Group Inc. ($15.29M), TCG Crossover Management LLC ($10.12M), Laurion Capital Management LP ($3.14M), and 72 Investment Holdings LLC ($2.61M).Learn more on TRDA's institutional investors. What percentage of Entrada Therapeutics stock is owned by institutional investors? 86.39% of Entrada Therapeutics stock is owned by institutional investors. Learn more on TRDA's institutional investor holdings. Which institutional investors have been buying Entrada Therapeutics stock? Of the 18 institutional investors that purchased Entrada Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Laurion Capital Management LP ($199.07K), TD Asset Management Inc ($59.63K), CHI Advisors LLC ($56.37K), Citigroup Inc. ($49.46K), Walleye Capital LLC ($44.65K), Wellington Management Group LLP ($28.27K), and Allspring Global Investments Holdings LLC ($26.73K). How much institutional buying is happening at Entrada Therapeutics? Institutional investors have bought a total of 585,274 shares in the last 24 months. This purchase volume represents approximately $8.10M in transactions. Which Entrada Therapeutics major shareholders have been selling company stock? Of the 10 institutional investors that sold Entrada Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: 72 Investment Holdings LLC ($336.42K), Price T Rowe Associates Inc. MD ($256.32K), Nan Fung Group Holdings Ltd ($56.49K), Redmile Group LLC ($27.57K), TCG Crossover Management LLC ($21.51K), Corton Capital Inc. ($7.58K), and SG Americas Securities LLC ($4.03K). How much institutional selling is happening at Entrada Therapeutics? Institutional investors have sold a total of 717,481 shares in the last 24 months. This volume of shares sold represents approximately $10.65M in transactions. Related Companies: Adlai Nortye Major Shareholders Lexicon Pharmaceuticals Major Shareholders Acelyrin Major Shareholders Oculis Major Shareholders Corbus Pharmaceuticals Major Shareholders Fulcrum Therapeutics Major Shareholders Theravance Biopharma Major Shareholders Larimar Therapeutics Major Shareholders PepGen Major Shareholders Travere Therapeutics Major Shareholders This page (NASDAQ:TRDA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford ClubDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entrada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
